Johnson & Johnson's most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $90.00 short put and a strike $85.00 long put offers a potential 11.11% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $90.00 by expiration. The full premium credit of $0.50 would be kept by the premium seller. The risk of $4.50 would be incurred if the stock dropped below the $85.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.
The RSI indicator is at 74.95 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Johnson & Johnson
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Thu, 17 Oct 2013 22:38:43 GMT
Seeking Alpha – Johnson & Johnson ( JNJ ) posted a moderate growth of 3% in Q3 2013 amid a stable healthcare environment, beating consensus estimates on the back of strong performance from its pharmaceutical business. …
Why Is Johnson & Johnson's Pharmaceutical Segment Outgrowing Its Other Businesses?
Thu, 17 Oct 2013 18:25:04 GMT
Motley Fool – J&J’s pharmaceuticals business outgrew its other businesses in the third quarter, becoming the company’s core growth driver. What does this mean for the company’s investors?
Danaher Hits New High After Q3 Earnings Beat
Thu, 17 Oct 2013 15:27:00 GMT
Investor's Business Daily – Danaher Hits New High After Q3 Earnings Beat
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2013
Thu, 17 Oct 2013 15:16:00 GMT
PR Newswire – NEW BRUNSWICK, N.J., Oct. 17, 2013 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2013 of $0.66 per share …
Is This Big Pharma King Still a Buy After Earnings?
Thu, 17 Oct 2013 15:08:10 GMT
Motley Fool – Johnson & Johnson beat estimates, but is the pharma still a good buy, and can it continue to fight the patent cliff?
Also on Market Tamer…
Follow Us on Facebook